102 related articles for article (PubMed ID: 19384943)
1. WT1 IgG antibody for early detection of nonsmall cell lung cancer and as its prognostic factor.
Oji Y; Kitamura Y; Kamino E; Kitano A; Sawabata N; Inoue M; Mori M; Nakatsuka S; Sakaguchi N; Miyazaki K; Nakamura M; Fukuda I; Nakamura J; Tatsumi N; Takakuwa T; Nishida S; Shirakata T; Hosen N; Tsuboi A; Nezu R; Maeda H; Oka Y; Kawase I; Aozasa K; Okumura M; Miyoshi S; Sugiyama H
Int J Cancer; 2009 Jul; 125(2):381-7. PubMed ID: 19384943
[TBL] [Abstract][Full Text] [Related]
2. Association of WT1 IgG antibody against WT1 peptide with prolonged survival in glioblastoma multiforme patients vaccinated with WT1 peptide.
Oji Y; Hashimoto N; Tsuboi A; Murakami Y; Iwai M; Kagawa N; Chiba Y; Izumoto S; Elisseeva O; Ichinohasama R; Sakamoto J; Morita S; Nakajima H; Takashima S; Nakae Y; Nakata J; Kawakami M; Nishida S; Hosen N; Fujiki F; Morimoto S; Adachi M; Iwamoto M; Oka Y; Yoshimine T; Sugiyama H
Int J Cancer; 2016 Sep; 139(6):1391-401. PubMed ID: 27170523
[TBL] [Abstract][Full Text] [Related]
3. Low Wilms' tumor gene expression in tumor tissues predicts poor prognosis in patients with non-small-cell lung cancer.
Hayashi S; Oji Y; Kanai Y; Teramoto T; Kitaichi M; Kawaguchi T; Okada M; Sugiyama H; Matsumura A
Cancer Invest; 2012 Feb; 30(2):165-71. PubMed ID: 22148937
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of specific anti-WT1 IgG antibody level in plasma in patients with ovarian carcinoma.
Andersson C; Oji Y; Ohlson N; Wang S; Li X; Ottander U; Lundin E; Sugiyama H; Li A
Cancer Med; 2014 Aug; 3(4):909-18. PubMed ID: 24715586
[TBL] [Abstract][Full Text] [Related]
5. Th1-biased humoral immune responses against Wilms tumor gene WT1 product in the patients with hematopoietic malignancies.
Wu F; Oka Y; Tsuboi A; Elisseeva OA; Ogata K; Nakajima H; Fujiki F; Masuda T; Murakami M; Yoshihara S; Ikegame K; Hosen N; Kawakami M; Nakagawa M; Kubota T; Soma T; Yamagami T; Tsukaguchi M; Ogawa H; Oji Y; Hamaoka T; Kawase I; Sugiyama H
Leukemia; 2005 Feb; 19(2):268-74. PubMed ID: 15538407
[TBL] [Abstract][Full Text] [Related]
6. Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival.
Liao WT; Wang X; Xu LH; Kong QL; Yu CP; Li MZ; Shi L; Zeng MS; Song LB
Cancer; 2009 Apr; 115(7):1507-17. PubMed ID: 19170237
[TBL] [Abstract][Full Text] [Related]
7. Anti-α-enolase is a prognostic marker in postoperative lung cancer patients.
Hsiao KC; Shih NY; Chu PY; Hung YM; Liao JY; Chou SW; Yang YY; Chang GC; Liu KJ
Oncotarget; 2015 Oct; 6(33):35073-86. PubMed ID: 26551021
[TBL] [Abstract][Full Text] [Related]
8. Wilms' tumor 1 enhances Cisplatin-resistance of advanced NSCLC.
Wu C; Wang Y; Xia Y; He S; Wang Z; Chen Y; Wu C; Shu Y; Jiang J
FEBS Lett; 2014 Dec; 588(24):4566-72. PubMed ID: 25447528
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of the Wilms' tumor gene WT1 in de novo lung cancers.
Oji Y; Miyoshi S; Maeda H; Hayashi S; Tamaki H; Nakatsuka S; Yao M; Takahashi E; Nakano Y; Hirabayashi H; Shintani Y; Oka Y; Tsuboi A; Hosen N; Asada M; Fujioka T; Murakami M; Kanato K; Motomura M; Kim EH; Kawakami M; Ikegame K; Ogawa H; Aozasa K; Kawase I; Sugiyama H
Int J Cancer; 2002 Jul; 100(3):297-303. PubMed ID: 12115544
[TBL] [Abstract][Full Text] [Related]
10. [Clinical significance and diagnostic value of Survivin autoantibody in non-small cell lung cancer patients].
Ma L; Yue W; Zhang L; Wang Y; Zhang C; Yang X
Zhongguo Fei Ai Za Zhi; 2010 Jul; 13(7):706-12. PubMed ID: 20673487
[TBL] [Abstract][Full Text] [Related]
11. Development of a membrane array-based multimarker assay for detection of circulating cancer cells in patients with non-small cell lung cancer.
Sheu CC; Yu YP; Tsai JR; Chang MY; Lin SR; Hwang JJ; Chong IW
Int J Cancer; 2006 Sep; 119(6):1419-26. PubMed ID: 16642481
[TBL] [Abstract][Full Text] [Related]
12. AP‑4 predicts poor prognosis in non‑small cell lung cancer.
Gong H; Han S; Yao H; Zhao H; Wang Y
Mol Med Rep; 2014 Jul; 10(1):336-40. PubMed ID: 24804973
[TBL] [Abstract][Full Text] [Related]
13. Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis.
Chen X; Hu Z; Wang W; Ba Y; Ma L; Zhang C; Wang C; Ren Z; Zhao Y; Wu S; Zhuang R; Zhang Y; Hu H; Liu C; Xu L; Wang J; Shen H; Zhang J; Zen K; Zhang CY
Int J Cancer; 2012 Apr; 130(7):1620-8. PubMed ID: 21557218
[TBL] [Abstract][Full Text] [Related]
14. Autoantibodies against p16 protein-derived peptides may be a potential biomarker for non-small cell lung cancer.
Zhang C; Ye L; Guan S; Jin S; Wang W; Sun S; Lee KH; Wei J; Liu B
Tumour Biol; 2014 Mar; 35(3):2047-51. PubMed ID: 24122232
[TBL] [Abstract][Full Text] [Related]
15. Prognostic markers in resectable non-small cell lung cancer: a multivariate analysis.
Pelletier MP; Edwardes MD; Michel RP; Halwani F; Morin JE
Can J Surg; 2001 Jun; 44(3):180-8. PubMed ID: 11407827
[TBL] [Abstract][Full Text] [Related]
16. Cytokeratin fragment 19 (CYFRA 21-1) as a tumor marker in non-small cell lung cancer.
Huang MS; Jong SB; Lin MS; Chong IW; Tsai MS; Lin HC; Hwang JJ
Kaohsiung J Med Sci; 1996 Feb; 12(2):62-8. PubMed ID: 8709175
[TBL] [Abstract][Full Text] [Related]
17. Blood group antigen A and flow cytometric analysis in resected early-stage non-small cell lung cancer.
Graziano SL; Tatum AH; Gonchoroff NJ; Newman NB; Kohman LJ
Clin Cancer Res; 1997 Jan; 3(1):87-93. PubMed ID: 9815542
[TBL] [Abstract][Full Text] [Related]
18. Expression level of Wilms tumor 1 (WT1) protein has limited prognostic value in epithelial ovarian cancer: from the Danish "MALOVA" ovarian cancer study.
Høgdall EV; Christensen L; Kjaer SK; Blaakaer J; Christensen IJ; Gayther S; Jacobs IJ; Høgdall CK
Gynecol Oncol; 2007 Aug; 106(2):318-24. PubMed ID: 17540436
[TBL] [Abstract][Full Text] [Related]
19. Macrophage expression of interleukin-10 is a prognostic factor in nonsmall cell lung cancer.
Zeni E; Mazzetti L; Miotto D; Lo Cascio N; Maestrelli P; Querzoli P; Pedriali M; De Rosa E; Fabbri LM; Mapp CE; Boschetto P
Eur Respir J; 2007 Oct; 30(4):627-32. PubMed ID: 17537769
[TBL] [Abstract][Full Text] [Related]
20. ADAM28 is a serological and histochemical marker for non-small-cell lung cancers.
Kuroda H; Mochizuki S; Shimoda M; Chijiiwa M; Kamiya K; Izumi Y; Watanabe M; Horinouchi H; Kawamura M; Kobayashi K; Okada Y
Int J Cancer; 2010 Oct; 127(8):1844-56. PubMed ID: 20112342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
